1-8 of 8
Kathleen T Finn, ANP
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-Term Outcome Of Patients With AL Amyloidosis Treated With High-Dose Melphalan and Stem Cell Transplantation: 19 Year Experience At a Single Center

Vaishali Sanchorawala, MD, Gheorghe Doros, Karen Quillen, MD, MPH, John Mark Sloan, MD, Anthony C Shelton, RN, Dina Brauneis, ANP, Kathleen T Finn, ANP, David C Seldin, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3328.
https://doi.org/10.1182/blood.V122.21.3328.3328
Published: 2013
Journal Articles

Lenalidomide and Dexamethasone in the Treatment of AL Amyloidosis: Final Results of A Phase II Trial

Divya Nair, MD, Vaishali Sanchorawala, MD, Anthony C Shelton, RN, Salli A Fennessey, Kathleen T Finn, ANP, Martha Skinner, MD, Jerome B. Zeldis, MD, PhD, David C Seldin, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 4084.
https://doi.org/10.1182/blood.V120.21.4084.4084
Published: 2012
Journal Articles

Melphalan, Lenalidomide and Dexamethasone Combination Therapy In Patients with AL Amyloidosis

Jaymin Patel, MD, John Mark Sloan, MD, Anthony C Shelton, RN, Kathleen T Finn, ANP, Vaishali Sanchorawala, MD
Journal: Blood
Blood (2011) 118 (21): 2924.
https://doi.org/10.1182/blood.V118.21.2924.2924
Published: 2011
Journal Articles

Modified High-Dose Melphalan and Autologous Stem Cell Transplantation (mHDM/SCT) In the Treatment of AL Amyloidosis (AL) and/or High-Risk Myeloma (hM): Analysis of SWOG Trial S0115

Vaishali Sanchorawala, MD, Antje Hoering, PhD, David C Seldin, MD, PhD, Kathleen T Finn, ANP, Salli A Fennessey, Bassam I Mattar, MD, Hana F Safah, MD, Leona Holmberg, MD, PhD, Robert M. Dean, MD, Robert Z. Orlowski, MD, PhD, Bart Barlogie, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2004.
https://doi.org/10.1182/blood.V118.21.2004.2004
Published: 2011
Journal Articles

High-Dose Melphalan and Autologous Stem Cell Transplantation In AL Amyloidosis and Monoclonal Immunoglobulin Deposition Disease Associated End-Stage Renal Disease Requiring Dialysis

Vaishali Sanchorawala, MD, Karen Quillen, MD, MPH, Kathleen T Finn, ANP, Nancy T Andrea, MD, J. Mark Sloan, MD, Laura Dember, MD, Adam Segal, MD, Gheorghe Doros, PhD, Martha Skinner, MD, David Seldin, MD
Journal: Blood
Blood (2010) 116 (21): 3553.
https://doi.org/10.1182/blood.V116.21.3553.3553
Published: 2010
Journal Articles

Outcome of Patients with AL Amyloidosis Who Do Not Achieve Hematologic Complete Response After Treatment with High Dose Melphalan and Autologous Transplantation: Results In a Series of 421 Patients

M. Teresa Cibeira, MD, PhD, Vaishali Sanchorawala, MD, David C Seldin, MD, PhD, Karen Quillen, MD, MPH, Nancy Andrea, MD, J. Mark Sloan, MD, Kathleen T Finn, ANP, John L Berk, MD, Gheorghe Doros, PhD, Joan Blade, Martha Skinner, MD
Journal: Blood
Blood (2010) 116 (21): 2394.
https://doi.org/10.1182/blood.V116.21.2394.2394
Published: 2010
Journal Articles

Increases In B-Type Natriuretic Peptide (BNP) During Treatment with Lenalidomide In AL Amyloidosis

Umit Tapan, MD, David C Seldin, MD, PhD, Kathleen T Finn, ANP, Salli Fennessey, CRA, Anthony C Shelton, RN, Jerome B. Zeldis, MD, PhD, Vaishali Sanchorawala, MD
Journal: Blood
Blood (2010) 116 (21): 3021.
https://doi.org/10.1182/blood.V116.21.3021.3021
Published: 2010
Journal Articles

Lenalidomide Treatment In Patients with AL Amyloidosis Associated End-Stage Renal Disease and Dialysis

Vaishali Sanchorawala, MD, Kathleen T Finn, ANP, Salli Fennessey, CRA, Anthony C Shelton, RN, Jerome B. Zeldis, MD, PhD, David C Seldin, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3022.
https://doi.org/10.1182/blood.V116.21.3022.3022
Published: 2010